Bomb: Employer Stock Inside 401(k) Could Cost Dearly
A retiring executive with a $4+ million 401K and a heavy concentration in employer stock faces a potential tax trap. ...
Ways Mistakes Can Disrupt Your Budget
Mistakes disrupt budgets and derail goals. Explore how small oversights impact finances and how to recalibrate for stable, predictable spending.
27,871 articles
Pentagon Accuses Alibaba, Baidu; BYD in Sanctions Push
The Defense Department expanded its 1260H roster to label Alibaba and Baidu as aiding the PLA, with BYD also targeted...
SpaceX Since IPO: December Faces First Real Test Ahead
SpaceX has sprinted out of the gate after its IPO, up roughly 49% from the offer price. As December approaches, inves...
OpenAI’s Luna Name Turns Terra Token Into YOLO Trade
A branding-driven move in LUNA2 futures followed OpenAI's GPT-5.6 tier rollout, with open interest surging and prices...
Forget Tesla: Dislike Promises? Consider Inverse ETF
As Tesla fans cheer long-term robotaxi dreams, traders worry about delivery misses. A growing crowd is exploring inve...
Live: J.B. Hunt Keeps Rally Going After Q2 Earnings Preview
J.B. Hunt Transport Services heads into tonight's Q2 print trading up about 41% for the year. Analysts will be listen...
XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Kickstarter’s Stands 4-Day Workweek Amid CEO Debate
Kickstarter’s stands 4-day workweek, a bold move for a remote-first company. The CEO says it balances life with high ...
Beating Eurozone Mile with Spain-Focused ETF Rally
A Spain-focused ETF is delivering roughly a 50% one-year return, eclipsing EZU by a wide margin and signaling a sharp...
This Keeps Outrallying SPY: Momentum ETF Shines Broadly
The Invesco S&P 500 Momentum ETF (SPMO) is again outperforming SPY on a trailing basis while showing resilience durin...
Invested $1,000 When Trump: XRP’s Post-Election Ride
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status